Citadel Advisors’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Buy |
+15,198
| New | +$110K | ﹤0.01% | 5235 |
|
|
2024
Q3 | – | Sell |
-11,095
| Closed | -$97.1K | – | 5745 |
|
|
2024
Q2 | $97.1K | Sell |
11,095
-332
| -3% | -$2.91K | ﹤0.01% | 4967 |
|
|
2024
Q1 | $280K | Buy |
+11,427
| New | +$280K | ﹤0.01% | 4469 |
|
|
2023
Q3 | – | Sell |
-1,114
| Closed | -$27.1K | – | 5837 |
|
|
2023
Q2 | $27.1K | Sell |
1,114
-2,401
| -68% | -$58.3K | ﹤0.01% | 5175 |
|
|
2023
Q1 | $76.8K | Buy |
3,515
+64
| +2% | +$1.4K | ﹤0.01% | 5016 |
|
|
2022
Q4 | $82.2K | Buy |
3,451
+519
| +18% | +$12.4K | ﹤0.01% | 5100 |
|
|
2022
Q3 | $80K | Sell |
2,932
-3,426
| -54% | -$93.5K | ﹤0.01% | 5175 |
|
|
2022
Q2 | $193K | Buy |
6,358
+5,465
| +612% | +$166K | ﹤0.01% | 5011 |
|
|
2022
Q1 | $48K | Buy |
893
+252
| +39% | +$13.5K | ﹤0.01% | 5917 |
|
|
2021
Q4 | $190K | Buy |
+641
| New | +$190K | ﹤0.01% | 5514 |
|
|
2021
Q3 | – | Sell |
-654
| Closed | -$334K | – | 6340 |
|
|
2021
Q2 | $334K | Buy |
+654
| New | +$334K | ﹤0.01% | 5100 |
|